Medication Adherence and Healthcare Utilization in Relapsing-Remitting Multiple Sclerosis Patients Using Teriflunomide

PURPOSE: Multiple sclerosis (MS) is a costly, immune-mediated disease of the central nervous system. Most patients have relapsing-remitting MS (RRMS) for which disease-modifying therapies (DMTs) provide an effective treatment option by reducing relapse rates. However, adherence to DMTs is suboptimal...

Descripción completa

Detalles Bibliográficos
Autores principales: Greene, Nupur, Higuchi, Keiko, Bognar, Katalin, Chang, Eunice, Broder, Michael S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791931/
https://www.ncbi.nlm.nih.gov/pubmed/36578311
http://dx.doi.org/10.2147/CEOR.S383934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791931/
https://www.ncbi.nlm.nih.gov/pubmed/36578311
http://dx.doi.org/10.2147/CEOR.S383934

Ejemplares similares